Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 44, Issue 5, 2015, Pages 353-360

  Dong, Cong ^a,b   Ye, Dong Xia ^c   Zhang, Wen Bin ^a   Pan, Hong Ya ^c   Zhang, Zhi Yuan ^c   Zhang, Lei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Stomatological Disease Center   (China)

^c Shanghai Key Laboratory of Stomatology   (China)

Author keywords

Immunohistochemistry; M c Fos; Oral squamous cell carcinoma; Small RNA interference; Tumor invasion and metastasis

Indexed keywords

CYCLIN D3; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN C FOS; CD44 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL INVASION; CELL LINE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; LENTIVIRUS INFECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; TUMOR INVASION; TUMOR LOCALIZATION; BIOSYNTHESIS; CELL MOTION; GENETICS; HEAD AND NECK TUMOR; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-FOS; YOUNG ADULT;

EID: 84928285310     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12296     Document Type: Article

References (32)

1. Kademani D. Oral cancer. Mayo Clin Proc 2007; 82: 878-87.
2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-16.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
4. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med 2008; 359: 1143-54.
5. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22.
6. Comoglio PM, Trusolino L. Invasive growth: from development to metastasis. J Clin Invest 2002; 109: 857-62.
7. Ding X, Pan H, Li J, et al. Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis. Sci Signal 2013; 6: ra28.1-13, S0-15.
8. Apostolou P, Toloudi M, Ioannou E, et al. AP-1 gene expression levels may be correlated with changes in Gene expression of some stemness factors in colon carcinomas. J Signal Transduct 2013; 2013: 497383.
9. Sundqvist A, Zieba A, Vasilaki E, et al. Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion. Oncogene 2013; 32: 3606-15.
10. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002; 4: 131-6.
11. Ozanne BW, McGarry L, Spence HJ, et al. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur J Cancer 2000; 36: 1640-8.
12. Lopez-Bergami P, Lau E, Ronai Z. Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 2010; 10: 65-76.
13. Sachdev R, Mandal AK, Singh I, Agarwal AK. Progressive rise of c-fos expression from premalignant to malignant lesions of oral cavity. Med Oral Patol Oral Cir Bucal 2008; 13: 683-6.
14. Fan Q, He M, Deng X, et al. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma. Cell Biochem Funct 2013; 31: 319-24.
15. Cheung TH, Leung JO, Chung TK, Lam SK, To KF, Wong YF. C-fos overexpression is associated with the pathoneogenesis of invasive cervical cancer. Gynecol Obstet Invest 1997; 43: 200-3.
16. Wodrich W, Volm M. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis 1993; 14: 1121-4.
17. Lee CS, Charalambous D. Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers. Zentralbl Pathol 1994; 140: 271-5.
18. Arbuthnot P, Kew M, Fitschen W. C-fos and c-myc oncoprotein expression in human hepatocellular carcinomas. Anticancer Res 1991; 11: 921-4.
19. Magrisso IJ, Richmond RE, Carter JH, Pross CB, Gilfillen RA, Carter HW. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Lab Invest 1993; 69: 674-81.
20. Zhang L, Yang X, Zhong LP, et al. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma. J Oral Pathol Med 2009; 38: 362-70.
21. Sobin LH, Wittekind CH. International Union Against Cancer (UICC). TNM classification of malignant tumozrurs, 6th edn. New York: Wiley-Liss, 2002.
22. Zhang L, Pan HY, Zhong LP, et al. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis. J Oral Pathol Med 2010; 39: 470-6.
23. Jeffers M, Fiscella M, Webb CP, et al. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci USA 1998; 95: 14417-22.
24. Cortesina G, Martone T, Galeazzi E, et al. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer 2000; 89: 286-92.
25. Guo L, Guo Y, Xiao S. Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma. Oncology 2007; 72: 410-6.
26. Hu S, Wu XF, Zhou B, et al. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2014; 140: 883-93.
27. Xu Y, Gao XD, Lee JH, Huang H, Tan H, Ahn J. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing. Genes Dev 2014; 28: 1191-203.
28. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 2011; 11: 254-67.
29. Lana MC, Anita Y, Angelos P, et al. Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. Clin Cancer Res 2013; 19: 3881-93.
30. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006; 12: 1167-74.
31. Chang G, Zhang H, Wang J, et al. CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells. Cancer Cell Int 2013; 13: 117.
32. Zhang L, Ye DX, Pan HY, et al. Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma. Oral Oncol 2011; 47: 693-7.